MeiraGTx Holdings PLC (NAS:MGTX)
$ 6.73 0.31 (4.83%) Market Cap: 519.45 Mil Enterprise Value: 483.11 Mil PE Ratio: 0 PB Ratio: 5.19 GF Score: 41/100

MeiraGTx Holdings PLC at Bank of America Merrill Lynch Health Care Conference Transcript

May 15, 2019 / 10:55PM GMT
Release Date Price: $22.22 (+3.35%)
Unidentified Analyst

Hello, everyone. Thank you so much for joining us, again, this afternoon at Vegas for BMO Healthcare Conference. And my name is [Chen Wong] and I'm on the large-cap biotech team here working with Ying. So today it's my pleasure to have Zandy Forbes, the CEO of Meira Therapeutics, so to talk more about gene therapy today. Yes, welcome. Thank you for joining us.

Alexandria Forbes
MeiraGTx Holdings plc - CEO, President & Director

Thanks for having me.

Unidentified Analyst

Okay, great. So you guys put out the press release with some positive data yesterday. But before I dive into that, maybe you can give us a general introduction about the company and where you are with all these different programs.

Alexandria Forbes
MeiraGTx Holdings plc - CEO, President & Director

Well, the company was established as a company that our aim was to develop the technology of gene therapy to be able to treat both rare diseases as well as deliver biologics to address more

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot